pulmonary embolism

MENLO PARK, Calif., May 20, 2026 Jupiter Endovascular announced positive topline results from the pivotal SPIRARE II clinical trial...

Alameda, California | April 13, 2026 Penumbra, Inc. has announced compelling 90-day results from the STORM-PE randomized controlled trial,...

NEW ORLEANS, February 3, 2026 — Kandu, Inc., a healthcare technology company specializing in brain–computer interface (BCI)–enabled stroke recovery...

CHAPEL HILL, N.C., February 3, 2026 — SonoVascular, Inc., a clinical-stage medical device company focused on improving treatment for...

MENLO PARK, Calif., January 12, 2026 — Inquis Medical, a commercial-stage medical technology company focused on venous thromboembolic disease...